From: Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study
Pt | Age (yrs) | Wt (kg) | FEV1 (%) | % HbA1c at Dx | Rx Course (yrs) | Clinical Data |
---|---|---|---|---|---|---|
I1 | 28 | 65.8 | 56 | 5.5 | 4 | PI, LupusN, Deceased |
I2 | 31 | 65.3 | 44 | 14.3 | 2 | PI, Deceased |
I3 | 13 | 41.9 | 57 | 9.3 | 4 | PS |
I4 | 33 | 54.3 | 18 | 10.0 | 2 | PI, Deceased, RI* |
I5 | 14 | 49.0 | 99 | 10.9 | 8 | PI |
I6 | 44 | 81.5 | 30 | 9.2 | 5 | PI, Cor P, HTN, BPH |
I7 | 24 | 53.0 | 57 | 7.3 | 3 | PI, AIHS, RI |
I8 | 21 | 70.5 | 93 | 9.8 | 10 | PI |
S1 | 29 | 75.5 | 71 | 7.1 | 1 | PI |
S2 | 17 | 33.6 | 33 | 8.1 | 2 | PI, Deceased |
S3 | 25 | 73.9 | 48 | 7.8 | 4 | PI, Deceased |
S4 | 33 | 97.5 | 83 | 6.3 | 1 | PI, Bipolar, HTN |
S5 | 18 | 49.7 | 30 | 6.6 | 1 | PI, Deceased |
M1I4 | 35 | 51.5 | 17 | 9.7 | 1 | PI |
M2 | 24 | 71.1 | 117 | 5.4 | 2 | PI |
M3I5 | 22 | 68.5 | 68 | 9.6 | 2 | PI |
M4 | 19 | 70.0 | 100 | 6.1 | 3 | PI |
M5 | 22 | 67.7 | 88 | 13.3 | 3 | PI, Hepatic Cirrhosis |
M6 | 15 | 41.8 | 85 | 8.9 | 5 | PI |
T1 | 29 | 58.0 | 47 | 13.3 | 2 | PI |
T2 | 20 | 44.4 | 23 | 5.1 | 1 | PI |
T3I6 | 49 | 85.5 | 29 | 9.2 | 2 | PI, Cor P, HTN, BPH |
T4I7 | 32 | 55.7 | 65 | 7.3 | 2 | PI, AIHS, RI |
T5S4 | 34 | 96.5 | 92 | 6.3 | 1 | PI, Bipolar, HTN |
T6 | 40 | 54.0 | 56 | 9.6 | 2 | PI, Lupus, RI ABPA |